Studies on the pharmacokinetics and bioequivalence of domestic irbesartan tablet in healthy volunteers

Chinese Pharmaceutical Journal

Volumn 37, Issue 2, 2002, Pages 123-125

  Liu, Lei ^a   He, Guang Wei ^a   Yin, Qi ^a   Shi, Ai Xin ^a   Li, Ke Xin ^a   Sun, Chun Hua ^a  

^a BEIJING HOSPITAL   (China)

Author keywords

HPLC; Irbesartan; Pharmacokinetics; Realative bioavailability

Indexed keywords

LIQUID CHROMATOGRAPHY; PHARMACOKINETICS; PLASMAS;

DOMESTIC IRBESARTAN TABLETS;

DRUG PRODUCTS;

IRBESARTAN;

AREA UNDER THE CURVE; ARTICLE; BIOEQUIVALENCE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOSE TIME EFFECT RELATION; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG DETERMINATION; DRUG DISPOSITION; DRUG FORMULATION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN EXPERIMENT; NORMAL HUMAN; RANDOMIZED CONTROLLED TRIAL; TABLET;

EID: 0036197347     PISSN: 10012494     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (4)

1. High-performance liquid chromatography assay for the quantitation of irbesartan (SR 47436/BMS-186295) in human plasma and urine
2. Pharmacokinetics and pharmacodynamics of irbesartan in healthy subjects
3. Pharmacokinetics and pharmacodynamics of irbesartan in patients with hepatic cirrhosis